🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objectives of Part 1 of this study are to: * Assess the safety...
Status
Terminated
Location
City of Hope Comprehensive Cancer Center - Duarte
Start Date
2024-04-18
Trial ID
NCT06194877
Treatments Being Tested
This is a phase ll study of participants with large B Cell lymphoma previou...
Status
Recruiting
Location
University Health Network (UHN)
Start Date
2025-06-04
Trial ID
NCT06167785
Treatments Being Tested
Erlotinib attacks a part of cancer cells that helps them live and grow. Stu...
Status
Terminated
Location
Vanderbilt-Ingram Oncology Cool Springs
Start Date
2010-05
Trial ID
NCT01205685
A Phase 1/2 multi-center open-label study of BGB324 (bemcentinib) as a sing...
Status
Completed
Location
UC San Diego Moores Cancer Center
Start Date
2015-04-19
Trial ID
NCT02424617
Treatments Being Tested
The study will estimate the MRD-negative response rate after treatment with...
Status
Terminated
Location
Research Site
Start Date
2018-05-23
Trial ID
NCT03298412
Treatments Being Tested
To Evaluate the Efficacy of the Timing of the Administration of a Telmisart...
Status
Unknown
Location
Korean University Guro Hospital
Start Date
2015-04
Trial ID
NCT02526875
Treatments Being Tested
To study the effect of sibutramine treatment on weight reduction and blood ...
Status
Completed
Location
Multiple Locations
Start Date
2002-02
Trial ID
NCT00679653
Treatments Being Tested
A parallel group, open label, multi-centre, phase I/II marker-lesion study ...
Status
Terminated
Location
University Hospital Southampton NHS Foundation Trust
Start Date
2018-03-02
Trial ID
NCT03167151
Treatments Being Tested
This is a multicenter, Phase II clinical study to evaluate the efficacy and...
Status
Recruiting
Location
Dragonboat Biopharmaceutical,Co.,Ltd
Start Date
2026-04-27
Trial ID
NCT07447102
The Wnt proteins belong to a family of proteins that have been demonstrated...
Status
Completed
Location
Clinical Research Department, Oncology, Rigshospitalet
Start Date
2016-04
Trial ID
NCT02655952
Treatments Being Tested